Double blind, randomized controlled study to evaluate the efficacy and safety of extract of Gelidium elegans

Kyung Hee University Hosipital at Gangdong0 个研究点目标入组 80 人开始时间: 待定最近更新: 2019年3月11日

试验速览

暂无简介。

•1) 80 male and female adults aged 20 years or older who had a body mass index of 25-30 kg / m2 and measured
•2) People who have not received medication for obesity within the last 3 months
•3) Adults without diabetes
•4) A voluntary written consent to participate in the trial

•1) Those who are taking medication for obesity within the last 3 months and during the clinical trial
•2) Subjective assessment, mental illness that may affect medicines for clinical trials. Especially, psychosis, depression, etc.
•3) Exceptions to the following laboratory test results which may affect the performance of the test are excluded.
•- A liver disease with AST (SGOT) / ALT (SGPT)> 3 times the upper limit of normal
•- a renal impairment with a creatinine level> 1.5 mg / dl
•- TSH levels greater than 10
•4) Those who have been taking glucocorticoids within the last 3 months that may affect obesity
•5) Drug abuse or history (including alcohol)
•6) Severe disease history that can be recurred during or immediately after the clinical trial
•7) Pregnant and lactating women.
•8) In addition, if the researcher is found unable to participate in clinical research

发起方

Kyung Hee University Hosipital at Gangdong